HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

5,2',4'- trihydroxy- 6,7,5'- trimethoxyflavone

seems to have some antineoplastic activity; isolated from Sorbaria sorbifolia

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrans: 130
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        5,2',4'-trihydroxy-6,7,5'-trimethoxyflavone: 1
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Benzopyrans: 195
      - Chromones: 159
        Flavonoids: 9773
        Flavones: 446
        5,2',4'-trihydroxy-6,7,5'-trimethoxyflavone: 1

Experts

1.	Liu, Bing-Tong: 1 article (01/2016)
2.	Liu, Chao: 1 article (01/2016)
3.	Liu, Rong-Rong: 1 article (01/2016)
4.	Xiao, Bin: 1 article (01/2016)
5.	Zhang, Xuan: 1 article (01/2016)
6.	Zhang, Xue-Wu: 1 article (01/2016)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2016 - "Previous studies have shown that 5,2',4'-trihydroxy-6,7,5'-trimethoxyflavone (TTF1) is the primary anticancer constituent of the traditional Chinese medicinal plant Sorbaria sorbifolia (SS), which has been applied to treat cancer in China. "